日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp

一项随机、双盲、III期、多中心研究的长期随访结果，旨在评估使用BF-200 ALA光动力疗法（PDT）治疗轻度至中度日光性角化病的安全性和有效性，并与安慰剂和BF-RhodoLED®灯进行比较。

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20452
Reinhold, U; Philipp-Dormston, W G; Dirschka, T; Ostendorf, R; Aschoff, R; Berking, C; Jäger, A; Schmitz, B; Foguet, M; Szeimies, R-M
发表日期：2025
文献求助 收藏

Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy

接受全身治疗的黑色素瘤患者的生育力保存和妊娠管理

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100248
Hassel, J C; Livingstone, E; Allam, J P; Behre, H M; Bojunga, J; Klein, H H; Landsberg, J; Nawroth, F; Schüring, A; Susok, L; Thoms, K M; Kiesel, L; Berking, C
黑色素瘤
发表日期：2021
文献求助 收藏

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial

尼洛替尼治疗KIT突变转移性或不可切除黑色素瘤患者的疗效和安全性：全球单臂II期TEAM试验的最终结果

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdx079
Guo, J; Carvajal, R D; Dummer, R; Hauschild, A; Daud, A; Bastian, B C; Markovic, S N; Queirolo, P; Arance, A; Berking, C; Camargo, V; Herchenhorn, D; Petrella, T M; Schadendorf, D; Sharfman, W; Testori, A; Novick, S; Hertle, S; Nourry, C; Chen, Q; Hodi, F S
黑色素瘤
KIT
发表日期：2017
文献求助 收藏

Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety

Nevisense系统在皮肤黑色素瘤检测中的临床表现：一项国际多中心前瞻性盲法临床试验，评估其疗效和安全性

期刊:British Journal of Dermatology
影响因子:9.6
doi:10.1111/bjd.13121
Malvehy, J; Hauschild, A; Curiel-Lewandrowski, C; Mohr, P; Hofmann-Wellenhof, R; Motley, R; Berking, C; Grossman, D; Paoli, J; Loquai, C; Olah, J; Reinhold, U; Wenger, H; Dirschka, T; Davis, S; Henderson, C; Rabinovitz, H; Welzel, J; Schadendorf, D; Birgersson, U
黑色素瘤
发表日期：2014
文献求助 收藏

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis

两项前瞻性、随机、对照的III期光动力疗法试验（使用BF-200 ALA和氨基乙酰丙酸甲酯）治疗日光性角化病的长期（6个月和12个月）随访结果

期刊:British Journal of Dermatology
影响因子:9.6
doi:10.1111/bjd.12158
Dirschka, T; Radny, P; Dominicus, R; Mensing, H; Brüning, H; Jenne, L; Karl, L; Sebastian, M; Oster-Schmidt, C; Klövekorn, W; Reinhold, U; Tanner, M; Gröne, D; Deichmann, M; Simon, M; Hübinger, F; Hofbauer, G; Krähn-Senftleben, G; Borrosch, F; Reich, K; Berking, C; Wolf, P; Lehmann, P; Moers-Carpi, M; Hönigsmann, H; Wernicke-Panten, K; Hahn, S; Pabst, G; Voss, D; Foguet, M; Schmitz, B; Lübbert, H; Szeimies, R-M
发表日期：2013
文献求助 收藏

A nine-gene signature predicting clinical outcome in cutaneous melanoma

预测皮肤黑色素瘤临床结果的九基因特征

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-012-1322-z
Brunner, G; Reitz, M; Heinecke, A; Lippold, A; Berking, C; Suter, L; Atzpodien, J
黑色素瘤
发表日期：2013
文献求助 收藏

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.

FGFR4 Arg388 等位基因与肿瘤厚度相关，FGFR4 蛋白表达与黑色素瘤患者的生存率相关

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6603181
Streit S, Mestel D S, Schmidt M, Ullrich A, Berking C
肿瘤
黑色素瘤
发表日期：2006
文献求助 收藏

Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin

碱性成纤维细胞生长因子和紫外线B可转化人皮肤中的黑素细胞

期刊:American Journal of Pathology
影响因子:3.6
doi:10.1016/S0002-9440(10)64041-2
Berking, C; Takemoto, R; Satyamoorthy, K; Elenitsas, R; Herlyn, M
细胞生物学
成纤维细胞
发表日期：2001
文献求助 收藏